Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
ENROLLING_BY_INVITATION
500 participants
OBSERVATIONAL
2013-02-01
2029-01-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Magnetic Resonance Imaging and Spectroscopy at High Field
NCT00611013
Safety and Feasibility of Imaging at 10.5 Tesla
NCT03346707
Study of New Magnetic Resonance Methods
NCT00001844
Assessing and Improving Quantitative Magnetic Resonance Imaging Metrics in Human Subjects
NCT05604534
Development of Protocols and Methods for Image Processing and Enhancement of Magnetic Resonance Imaging (MRI) Data.
NCT04942704
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
CASE_CONTROL
PROSPECTIVE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
MRI
Subjects undergoing MRI
No interventions assigned to this group
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
1. To describe any previous surgeries to help subjects and study staff open a dialogue as to any possible contraindications listed in the yes/no section below.
2. If they are claustrophobic and to rate the severity.
3. If they wear hearing aids and if they can be removed for the scan.
4. If they have a transdermal delivery system, and if yes where is it located and if it can be removed for the study.
5. If they wear colored contact lenses and, if yes, can they be removed for the study.
6. To provide a list of medications, dosages and time of last dose for medicines taken regularly.
7. To identify if they have any pre-existing medical conditions including Hypertension, Hypotension, Diabetes, Cardiovascular Disease and Fever.
8. To identify if they ever had an operation.
9. To indicate if they have ever been injured by a metallic foreign body which was never removed.
10. If they wear braces and/or if they have removable bridgework, false teeth or a permanent retainer.
11. If they have any tattoos, non-removable body piercings or hair extensions.
12. If they are currently using/wearing an IUD or diaphragm.
13. If they have any reason to believe they are pregnant. (If the subjects are unsure about their pregnancy status, test kits will be available to subjects).
* In addition, a set of yes/no questions will be asked in the screening form for the patient to confirm or deny the presence of items that may be hazardous to their safety and/or some interfere with the MRI examination, including:
No Cardiac pacemaker
No Implanted cardiac defibrillator
No Carotid artery vascular clamp
No Intravascular stents, filters, or coils
No Aortic clip
No Internal pacing wires
No Vascular access port and/or catheter
No Swan-Ganz catheter
No Shunt (spinal or intraventricular)
No Aneurysm clip(s)
No Neurostimulator
No Electrodes (on body, head, or brain)
No Heart valve prosthesis
No Any type of prosthesis (eye, penile, etc.)
No Artificial limb or joint replacement
No Bone growth/fusion stimulator
No Bone/joint pin, screw, nail, wire, plate
No Metal rods in bones
No Harrington rods (spine)
No Metal or wire mesh implants
No Wire sutures or surgical staples
No Insulin pump or infusion device
No Any metal fragments (i.e. metal shop)
No Any implant held in place by a magnet
No Cochlear, otologic, or ear implant
18 Years
75 Years
ALL
Yes
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
University of Minnesota
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Greg Meztger, PhD
Role: PRINCIPAL_INVESTIGATOR
University of Minnesota
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
University of Minnesota CMRR
Minneapolis, Minnesota, United States
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
1212M24883
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.